ES2020993B3 - Proceso para la preparacion controlada de glucosaminoglucanos de bajo peso molecular. - Google Patents

Proceso para la preparacion controlada de glucosaminoglucanos de bajo peso molecular.

Info

Publication number
ES2020993B3
ES2020993B3 ES87116862T ES87116862T ES2020993B3 ES 2020993 B3 ES2020993 B3 ES 2020993B3 ES 87116862 T ES87116862 T ES 87116862T ES 87116862 T ES87116862 T ES 87116862T ES 2020993 B3 ES2020993 B3 ES 2020993B3
Authority
ES
Spain
Prior art keywords
molecular weight
glucosaminoglycans
low molecular
glucosaminoglucans
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87116862T
Other languages
English (en)
Inventor
Gianni Ferrari
Walter Recchia
Ambrosi Luigi De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratori Derivati Organici SpA
Mediolanum Farmaceutici SpA
Original Assignee
Laboratori Derivati Organici SpA
Mediolanum Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Derivati Organici SpA, Mediolanum Farmaceutici SpA filed Critical Laboratori Derivati Organici SpA
Application granted granted Critical
Publication of ES2020993B3 publication Critical patent/ES2020993B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B01J19/081—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing particle radiation or gamma-radiation
    • B01J19/082—Gamma-radiation only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ES87116862T 1986-11-24 1987-11-16 Proceso para la preparacion controlada de glucosaminoglucanos de bajo peso molecular. Expired - Lifetime ES2020993B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8622434A IT1213384B (it) 1986-11-24 1986-11-24 Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.

Publications (1)

Publication Number Publication Date
ES2020993B3 true ES2020993B3 (es) 1991-10-16

Family

ID=11196265

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87116862T Expired - Lifetime ES2020993B3 (es) 1986-11-24 1987-11-16 Proceso para la preparacion controlada de glucosaminoglucanos de bajo peso molecular.

Country Status (15)

Country Link
US (1) US4987222A (es)
EP (1) EP0269937B1 (es)
JP (1) JPS63213502A (es)
KR (1) KR880005936A (es)
AT (1) ATE60924T1 (es)
AU (1) AU603622B2 (es)
CA (1) CA1305134C (es)
DE (1) DE3768074D1 (es)
DK (1) DK602387A (es)
ES (1) ES2020993B3 (es)
FI (1) FI88045C (es)
GR (1) GR3001670T3 (es)
IT (1) IT1213384B (es)
NO (1) NO874777L (es)
PT (1) PT86191B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0748559B2 (ja) * 1988-11-30 1995-05-24 シャープ株式会社 半導体装置
EP0421508B1 (en) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulphated glycosaminoglycuronan with antithrombotic activity
IT1240615B (it) * 1990-04-03 1993-12-17 Mediolanum Farmaceutici Spa Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
US5230832A (en) * 1991-01-24 1993-07-27 Brandeis University Galactomannan-agarose binary gel for nucleic acid electrophoresis
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
FR2718025B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
US5585361A (en) * 1994-06-07 1996-12-17 Genzyme Corporation Methods for the inhibition of platelet adherence and aggregation
HUT77134A (hu) * 1994-12-01 1998-03-02 Seikagaku Corporation Keratán-szulfát-oligoszacharid frakciók és ilyet tartalmazó gyógyszerkészítmények és eljárás a fenti oligoszaharidok előállítására
DE19646901A1 (de) * 1996-11-13 1998-05-14 Helmut Prof Dr Heusinger Verfahren zum Herstellen von Abbauprodukten polymerer Glycosaminoglycane mittels Ultraschall
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll AG, 67061 Ludwigshafen Organprotektive Lösungen
DE19920688A1 (de) * 1999-05-05 2000-11-23 Manfred Kuhn Radiolytisch modifizierte Heteropolysaccharide
IT1312107B1 (it) * 1999-05-14 2002-04-04 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile
AU1502700A (en) * 1999-11-30 2001-06-12 Dalian Yaweite Biology Engineering Co., Ltd. The alginate having low molecular weight, methods of manufacturing it and its use
US6383344B1 (en) * 2000-07-19 2002-05-07 Genzyme Corporation Molecular weight reduction of polymer using irradiation treatment
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US6610810B2 (en) 2001-03-13 2003-08-26 Glyn Owen Phillips Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere
WO2002076475A2 (en) * 2001-03-23 2002-10-03 Bioparken As Glycosaminoglycan anticoagulants derived from fish
EP1344781A1 (en) * 2002-03-12 2003-09-17 Laboratori Derivati Organici S.P.A. Process for the depolymerization of glycosaminoglycanes and products obtained therefrom
ITMI20021372A1 (it) * 2002-06-21 2003-12-22 Derivati Organici Lab Processo per la depolimerizzazione fisica dei glicosamminogliacani e prodotti da esso ottenuti
US20040171819A1 (en) * 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
EP1524276A1 (en) * 2003-10-16 2005-04-20 Laboratori Derivati Organici S.P.A. Multistep process for the physical depolymerization of heparin and products obtained therefrom
US20050154196A1 (en) * 2004-01-13 2005-07-14 Seikagaku Corporation Process for producing sugar in which molecular weight is lowered
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
US7939512B2 (en) * 2004-10-13 2011-05-10 Laboratori Derivati Organici Spa Multistep process for the physical depolymerization of heparin and products obtained therefrom
US20110112050A1 (en) * 2008-05-20 2011-05-12 Crystal Clear Partnership Separation of polysaccharides by charge density gradient
RU2014137454A (ru) * 2012-02-17 2016-04-10 Кимфлексор, С.Л. Серебряные и золотые соли частично деполимеризованного гликозаминогликана
JP6250066B2 (ja) * 2012-12-28 2017-12-20 デュポン ニュートリション バイオサイエンシーズ エーピーエス アルギン酸の解重合
US20220016220A1 (en) * 2018-12-11 2022-01-20 Universita' Degli Studi Di Salerno Composition for the treatment of skin lesions
KR102240239B1 (ko) * 2019-04-23 2021-04-14 (주)티엠비 저분자량 히알루론산의 제조방법 및 이로부터 제조된 저분자량 히알루론산
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides
CN111040047A (zh) * 2019-12-11 2020-04-21 东营天东制药有限公司 一种酶-超滤法精制低分子硫酸皮肤素的工艺、应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136572C (es) * 1902-12-05
US3453194A (en) * 1966-08-03 1969-07-01 Dow Corning Anticoagulant surfaces produced by radiation grafting heparin to a silicone substrate
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IT1075117B (it) * 1977-02-14 1985-04-22 Fedeli Gianfranco Complesso polisaccaridico arterioso,processo per la sua preparazione e suo impiego in terapia umana
FR2440376A1 (fr) * 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2495935A1 (fr) * 1980-12-15 1982-06-18 Choay Sa Fractions mucopolysaccharidiques possedant des proprietes biologiques, leur procede de preparation et leur application en tant que medicaments
DE3265781D1 (en) * 1981-05-21 1985-10-03 Akzo Nv New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
DK196986D0 (da) * 1986-04-30 1986-04-30 Novo Industri As Fremstilling af polysaccharider

Also Published As

Publication number Publication date
JPS63213502A (ja) 1988-09-06
KR880005936A (ko) 1988-07-21
DK602387D0 (da) 1987-11-17
AU8160987A (en) 1988-05-26
DE3768074D1 (de) 1991-03-28
PT86191A (en) 1987-12-01
ATE60924T1 (de) 1991-03-15
GR3001670T3 (en) 1992-11-23
CA1305134C (en) 1992-07-14
JPH0588881B2 (es) 1993-12-24
DK602387A (da) 1988-09-15
FI875185A0 (fi) 1987-11-24
AU603622B2 (en) 1990-11-22
EP0269937A2 (en) 1988-06-08
EP0269937B1 (en) 1991-02-20
FI88045B (fi) 1992-12-15
US4987222A (en) 1991-01-22
EP0269937A3 (en) 1989-03-08
IT1213384B (it) 1989-12-20
NO874777D0 (no) 1987-11-16
IT8622434A0 (it) 1986-11-24
FI875185L (fi) 1988-05-25
PT86191B (pt) 1990-11-07
FI88045C (fi) 1993-03-25
NO874777L (no) 1988-05-25

Similar Documents

Publication Publication Date Title
ES2020993B3 (es) Proceso para la preparacion controlada de glucosaminoglucanos de bajo peso molecular.
ATE26281T1 (de) Depolymerisiertes und supersulfatiertes heparin, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
IE881150L (en) Low molecular weight heparins of regular structure, their¹preparation and their biological uses
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
IL82717A0 (en) Peptides that inhibit von willebrand factor binding
HUT50148A (en) Process for production of derivatives of antiflammation furanon and medical compositions containing them
IL79254A0 (en) Compositions for preventing graft rejection
ATE87305T1 (de) Polymerisierbare aryldiazosulfonate und polymere enthaltend wiederkehrende einheiten mit aryldiazosulfonatgruppen.
ATE74768T1 (de) Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.
ES8602041A1 (es) Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada.
PT88150A (pt) Processo para a preparacao de uma composicao farmaceutica combinada contendo um polissacarido sulfatado e um derivado de xantina
ES8601232A1 (es) Procedimiento para la preparacion de 1& , 2& metilen-6-meti-len y 6&-metil-pregnenos
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
ES2022501B3 (es) Procedimiento para preparar un aducto de lactato calcico y glicerol, y su empleo.
DZ1366A1 (fr) Nouveaux dérivés de la méthoxycarbonyl-2 n,n'-di-(triméthoxybenzoyle) pipérazine, ainsi que leur procédé de préparation.
ES2038736T3 (es) Procedimiento para la obtencion de n,n'-dimetilureas ciclicas.
ES2118665T3 (es) Oligomeros de 1,3 dieno parcialmente hidrogenados aminotelequelicos y procedimiento para la preparacion de estos compuestos.
DE69000412D1 (de) Gefriergetrocknete pulverfoermige cyclophosphamidzusammensetzung sowie verfahren zu deren herstellung.
SE8306792D0 (sv) Neues terapeutisches preparat enthaltend hydrierte ergotalkaloide und heparin
DE69213628D1 (de) Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz
JO1447B1 (en) Solid drug formulations and stable suspensions
IT8847652A0 (it) Derivati della 2-ammino-6-7-dimetossi tetralina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita'antiipertensiva che le contengono.
SE8504228D0 (sv) Tumordodande emne
IT8619565A0 (it) Derivati della 1,2,5,6-tetraidropiridin-3-carbossa ldeide ossima, loro procedimento di preparazione e loro applicazione come farmaci.